Not specified on homepage
Batten disease (Neuronal Ceroid Lipofuscinoses)
Clinical Development (Phase unspecified)Active
Key Facts
Indication
Batten disease (Neuronal Ceroid Lipofuscinoses)
Phase
Clinical Development (Phase unspecified)
Status
Active
Company
About THX Pharma
THX Pharma (Theranexus) is a publicly traded, clinical-stage biotech company based in Lyon, France, with origins in the CEA. The company's core asset is a proprietary platform designed to discover and characterize drug candidates for rare neurological diseases. Its most advanced therapeutic candidate targets Batten disease, a severe and rare genetic disorder. As a pre-revenue entity listed on Euronext Growth, the company's near-term value hinges on the clinical progress of its lead program and the validation of its platform technology.
View full company profile